
Total number of projects: 2
As coordinator: 1
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 1*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2016 | 0 | 2.877.077 | 0 | 1 | ||
| 2010 | 5.929.064 | 0 | 2.232.195 | 1 | ||
Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2016-10-01 | Training in Cancer Mechanisms and Therapeutics | TRACT | participant | 2.877.077 | 12 |
| 2010-12-01 | Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation | MABSOT | coordinator | 5.929.064 | 10 |